Barbara Ann Karmanos Cancer Institute
Wayne State University
Detroit, MI
Accepting patients
ALLOHA-2
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA-2)
- T Cell (Allogeneic)
- Phase 1
- Has results
Accepting patients
ACCELERATE
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Allogeneic Stem Cell Transplant
- Post-Allogeneic Stem Cell Transplant
- Phase 2
- Monoclonal Antibody
- CD70
- Phase 1
Accepting patients
MyeloMATCH Master Protocol
Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials
- Genetic Sequencing
- Phase 2
Accepting patients
[F-18] FLT for Imaging
Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)
- Observational Trial